John P Dalton

Title: John P Dalton: Innovator in Vaccine Development

Introduction

John P Dalton is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of vaccine development, particularly in relation to malaria. With a total of 2 patents, Dalton's work focuses on innovative solutions to combat infectious diseases.

Latest Patents

Dalton's latest patents include groundbreaking inventions that have the potential to revolutionize vaccine compositions. One of his patents involves Plasmodium proteins useful for preparing vaccine compositions. This invention relates to DNA segments encoding MAEBL, an erythrocyte binding protein of a Plasmodium parasite. The invention also covers substantially pure MAEBL proteins and recombinantly or synthetically produced MAEBL molecules. These MAEBL proteins can be utilized as a vaccine for humans against malaria. Another significant patent involves a vaccine containing a serine protease, which further demonstrates his innovative approach to vaccine development.

Career Highlights

Throughout his career, John P Dalton has worked with esteemed organizations such as the University of Notre Dame Du Lac and Mallinckrodt Veterinary, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Dalton has collaborated with notable individuals in his field, including John H Adams and Stefan Kappe. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

John P Dalton is a distinguished inventor whose work in vaccine development is paving the way for innovative solutions to combat malaria. His contributions are vital in the ongoing fight against infectious diseases, and his patents reflect his commitment to advancing medical science.